During tumor formation, high NSD2 expression catalyzes H3K36me2 at nuclear factor kappa B (NF-kB) target gene promoters to activate the NF-kB pathway, thereby promoting tumor growth (Yang et al. 2012). This evidence concerns the gene NSD2 and neoplasm.